Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations

Journal of Lipid Research

Volumn 44, Issue 2, 2003, Pages 296-302

  Basso, Federica ^a   Freeman, Lita ^a   Knapper, Catherine L ^a   Remaley, Alan ^a   Stonik, John ^a   Neufeld, Edward B ^a   Tansey, Terese ^a   Amar, Marcelo J A ^a   Fruchart Najib, Jamila ^b   Duverger, Nicholas ^c   Santamarina Fojo, Silvia ^a   Brewer Jr , H Bryan ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b INSTITUT PASTEUR DE LILLE   (France)

^c SANOFI   (France)

Author keywords

Cholesterol; Cholesterol transport; Lipoprotein; Tangier disease

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ADENOVIRUS VECTOR; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; GREEN FLUORESCENT PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HOMEOSTASIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIVER; LIVER CELL; LIVER METABOLISM; MALE; MODULATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL, HDL; HEPATOCYTES; LIPIDS; LIPOPROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS;

EID: 10744222520     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200414-JLR200     Document Type: Article

References (35)

1. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
2. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
3. Stoffel, W., E. Kruger, and R. Deutzmann. 1983. Cell-free translation of human liver apolipoprotein AI and AII mRNA. Processing of primary translation products. Hoppe. Seylers. Z. Physiol. Chem. 364: 227-237.
4. Bisgaier, C. L., and R. M. Glickman. 1983. Intestinal synthesis, secretion, and transport of lipoproteins. Annu. Rev. Physiol. 45: 625-636.
5. Brooks-Wilson, A., M. Marcil, S. M. Clee, L-H. Zhang, K. Roomp, M. van Dam, L. Yui, C. Brewer, J. A. Collins, H. O. F. Molhuizen, O. Loubser, B. F. F. Ouelette, K. Fichter, D. J. D. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. P. Kastelein, J. Genest, and M. R. Hayden. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.
6. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J. C. Piette, J. F. Deleuze, H. B. Brewer, N. Duverger, P. Denefle, and G. Assmann. 1999. Tangier disease is caused by mutations in the ATP binding cassette transporter 1 (ABC1) gene. Nat. Genet. 22: 352-355.
7. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W. E. Kaminski, H. W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K. J. Lackner, and G. Schmitz. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351.
8. Remaley, A. T., S. Rust, M. Rosier, C. Knapper, L. Naudin, C. Broccardo, K. M. Peterson, C. Koch, I. Arnould, C. Prades, N. Duverger, H. Funke, G. Assmann, M. Dinger, M. Dean, G. Chimini, S. Santamarina-Fojo, D. S. Fredrickson, P. Denefle, and H. B. Brewer, Jr. 1999. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc. Natl. Acad. Sci. 96: 12685-12690.
9. Brousseau, M. E., E. J. Schaefer, J. Dupuis, B. Eustace, P. Van Eerdewegh, A. L. Goldkamp, L. M. Thurston, M. G. Fitzgerald, D. Yasek-McKenna, G. O'Neill, G. P. Eberhart, B. Weiffenbach, J. M. Ordovas, M. W. Freeman, R. H. Brown, and J. Z. Gu. 2000. Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds. J. Lipid Res. 41: 433-441.
10. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, and J. F. Oram. 1999. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: 25-31.
11. Attie, A. D., J. P. Kastelein, and M. R. Hayden. 2001. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J. Lipid Res. 42: 1717-1726.
12. McNeish, J., R. J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K. L. Hoppe, M. L. Roach, L. J. Royer, J. deWet, C. Broccardo, G. Chimini, and O. L. Francon. 2000. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. 97: 4245-4250.
13. Christiansen-Weber, T. A., J. R. Voland, Y. Wu, K. Ngo, B. L. Roland, S. Nguyen, P. A. Peterson, and W. P. Fung-Leung. 2000. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am. J. Pathol. 157: 1017-1029.
14. Orso, E., C. Broccardo, W. E. Kiminski, A. Bottcher, G. Liebisch, W. Drobnik, A. Gotz, O. Chambenoit, W. Diederich, T. Langmann, T. Spruss, M-F. Luciani, G. Rothe, K. J. Lackner, G. Chimini, and G. Schmitz. 2000. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abcl-deficient mice. Nat. Genet. 24: 192-196.
15. Singaraja, R. R., V. Bocher, E. R. James, S. M. Clee, L. H. Zhang, B. R. Leavitt, B. Tan, A. Brooks-Wilson, A. Kwok, N. Bissada, Y-Z. Yang, G. Liu, S. R. Tafuri, C. Fievet, C. L. Wellington, B. Staels, and M. R. Hayden. 2001. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J. Biol. Chem. 276: 33969-33979.
16. Vaisman, B. L., G. Lambert, M. Amar, C. Joyce, T. Ito, R. D. Shamburek, W. J. Cain, J. Fruchart-Najib, E. B. Neufeld, A. T. Remaley, H. B. Brewer, Jr., and S. Santamarina-Fojo. 2001. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J. Clin. Invest. 108: 303-309.
17. Joyce, C., M. J. A. Amar, G. Lambert, B. L. Vaisman, B. Paigen, J. Najib-Fruchart, R. F. Hoyt, Jr., E. D. Neufeld, A. T Remaley, D. S. Fredrickson, H. B. Brewer, Jr., and S. Santamarina-Fojo. 2002. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knock-out mice. Proc. Nat. Acad. Sci. 99: 407-412.
18. Haghpassand, M., P. A. K. Bourassa, O. L. Francone, and R. J. Aiello. 2001. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108: 1315-1320.
19. van Eck, M., I. Sophie, T Bos, W. E. Kaminski, E. Orso, G. Rothe, J. Twisk, A. Bottcher, E. S. Van Amersfoort, T. A. Christiansen-Weber, W-P. Fung-Leung, T. J. C. Van Berkel, and G. Schmitz. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc. Natl. Acad. Sci. USA. 99: 6298-6303.
20. Kashyap, V. S., S. Santamarina-Fojo, D. R. Brown, C. L. Parrott, D. Applebaum-Bowden, S. Meyn, G. Talley, B. Paigen, N. Maeda, and H. B. Brewer, Jr. 1995. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J. Clin. Invest. 69: 1612-1620.
21. Smets, F. N., Y. Chen, L-J. Wang, and H. E. Soriano. 2002. Loss of cell anchorage triggers apoptosis (anoikis) in primary mouse hepatocytes. Mol. Gen. Metab. 75: 344-352.
22. Folch, R. J., M. Lees, and G. H. Sloan-Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
23. Gamble, W., M. Vaughn, H. S. Kruth, and J. Avigan. 1978. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J. Lipid Res. 19: 1068-1070.
24. Bortnick, A. E., G. H. Rothblat, G. Stoudt, K. L. Hoppe, L.J. Royer, J. McNeish, and O. L. Francone. 2000. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275: 28634-28640.
25. Herz, J., and R. D. Gerard. 1993. Adenovirus-mediated in vivo gene transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA. 90: 2812-2816.
26. Smith, T. A. G., M. G. Mehaffey, D. B. Kayda, J. M. Saunders, S. Yei, B. C. Trapnell, A. McClelland, and M. Kaleko. 1993. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5: 397-402.
27. Neufeld, E. B., A. T. Remaley, S. J. Demosky, Jr., J. A. Stonik, A. M. Cooney, M. Comly, N. K. Dwyer, M. Zhang, J. Blanchette-Mackie, S. Santamarina-Fojo, and H. B. Brewer, Jr. 2001. Cellular localization and trafficking of the human ABCA1 transporter. J. Biol. Chem. 276: 27584-27590.
28. Neufeld, E. B., S. J. Demosky, J. A. Stonik, C. Combs, A. T. Remaley, N. Duverger, S. Santamarina-Fojo, and H. B. Brewer, Jr. 2002. The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem. Biophys. Res. Comm. 297: 974-979.
29. Schaefer, E. J., T. J. Triche, L. A. Zech, L. A. Stein, M. M. Kemeny, M. F. Brennan, and H. B. Brewer, Jr. 1983. Massive omental reticulo-endothelial cell lipid uptake in Tangier disease after splenectomy. Am. J. Med. 75: 521-526.
30. Sviridov, D., and N. Fidge. 1995. Efflux of intracellular versus plasma membrane cholesterol in HepG2 cells: different availability and regulation by apolipoprotein A-I. J. Lipid Res. 36: 1887-1896.
31. Yokoyama, S. 2000. Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim. Biophys. Acta Mol. Cell Res. 1529: 231-244.
32. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
33. Ou, J., H. Tu, B. Shan, A. Luk, R. A. DeBose-Boyd, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-lc (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA. 98: 6027-6032.
34. Costet, P., Y. Luo, N. Wang, and A. R. Tall. 2000. Sterol-dependent transacativation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275: 28240-28245.
35. Venkateswaran, A., B. A. Laffitte, S. B. Joseph, P. A. Mak, D. C. Wilpitz, P. A. Edwards, and P. Tontonoz. 2000. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA. 97: 12097-12102.